C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease.

TitleC9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease.
Publication TypeJournal Article
Year of Publication2013
AuthorsNuytemans K, Bademci G, Kohli MM, Beecham GW, Wang L-S, Young JI, Nahab F, Martin ER, Gilbert JR, Benatar M, Haines JL, Scott WK, Züchner S, Pericak-Vance MA, Vance JM
JournalAnn Hum Genet
Volume77
Issue5
Pagination351-63
Date Published2013 Sep
ISSN1469-1809
KeywordsAdolescent, Adult, Aged, Aged, 80 and over, C9orf72 Protein, Case-Control Studies, Child, Gene Dosage, Genetic Predisposition to Disease, Genotype, Humans, Middle Aged, Parkinson Disease, Pedigree, Phenotype, Proteins, Repetitive Sequences, Nucleic Acid, Risk Factors, Young Adult
Abstract

We set out to determine whether expansions in the C9ORF72 repeat found in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) families are associated with Parkinson disease (PD). We determined the repeat size in a total of 889 clinically ascertained patients (including PD and essential tremor plus Parkinsonism (ETP)) and 1144 controls using a repeat-primed PCR assay. We found that large C9ORF72 repeat expansions (>30 repeats) were not contributing to PD risk. However, PD and ETP cases had a significant increase in intermediate (>20 to 30+) repeat copies compared to controls. Overall, 14 cases (13 PD, 1 ETP) and three controls had >20 repeat copies (Fisher's exact test p = 0.002). Further, seven cases and no controls had >23 repeat copies (p = 0.003). Our results suggest that intermediate copy numbers of the C9ORF72 repeat contribute to risk for PD and ETP. This also suggests that PD, ALS and FTD share some pathophysiological mechanisms of disease. Further studies are needed to elucidate the contribution of the C9ORF72 repeat in the overall PD population and to determine whether other common genetic risk factors exist between these neurodegenerative disorders.

DOI10.1111/ahg.12033
Alternate JournalAnn. Hum. Genet.
PubMed ID23845100
PubMed Central IDPMC3815478
Grant ListR01AG019085 / AG / NIA NIH HHS / United States
RC2 AG036528 / AG / NIA NIH HHS / United States
5P50NS071674-03 / NS / NINDS NIH HHS / United States
R01AG027944-02 / AG / NIA NIH HHS / United States
R01 AG019085 / AG / NIA NIH HHS / United States
U01 AG032984 / AG / NIA NIH HHS / United States
U01AG032984-02 / AG / NIA NIH HHS / United States
P50 NS039764 / NS / NINDS NIH HHS / United States
R01 AG028786 / AG / NIA NIH HHS / United States
NS39764 / NS / NINDS NIH HHS / United States
RC2AG036528 / AG / NIA NIH HHS / United States
R01AG028786-02 / AG / NIA NIH HHS / United States
R01 AG027944 / AG / NIA NIH HHS / United States
P50 NS071674 / NS / NINDS NIH HHS / United States